Noah Wyle’s repeat frontrunner status for Outstanding Lead Actor in a Drama Series stems from his layered performance as Dr. Michael “Robby” Robinavitch in The Pitt’s second season, which earned the HBO Max medical drama a leading 25 Emmy nominations. Building on his 2025 win for the freshman run, Wyle benefited from the show’s real-time format, strong reviews, and his additional producing and directing nods, creating clear awards momentum ahead of the September 14 ceremony. Traders priced in overwhelming consensus around the returning champion, consistent with historical patterns favoring repeat winners in the category when supported by guild and critics’ recognition. An upset would have required a late surge from nominees like Gary Oldman or Sterling K. Brown overcoming The Pitt’s dominance, an outcome that appeared improbable given the show’s broad industry backing.
基於Polymarket數據的AI實驗性摘要。這不是交易建議,也不影響該市場的結算方式。 · 更新於艾美獎2026 :戲劇系列中的傑出主角
諾亞·懷爾——《深淵》 100.0%
斯特林·K·布朗 —《天堂》 <1%
蓋瑞·歐德曼 –《慢馬》 <1%
馬克·魯法洛—《任務》 <1%
$35,596 交易量
$35,596 交易量
斯特林·K·布朗 —《天堂》
否
蓋瑞·歐德曼 –《慢馬》
否
馬克·魯法洛—《任務》
否
魯弗斯·休伊爾—《外交家》
否
諾亞·懷爾——《深淵》
是
諾亞·懷爾——《深淵》 100.0%
斯特林·K·布朗 —《天堂》 <1%
蓋瑞·歐德曼 –《慢馬》 <1%
馬克·魯法洛—《任務》 <1%
$35,596 交易量
$35,596 交易量
斯特林·K·布朗 —《天堂》
否
蓋瑞·歐德曼 –《慢馬》
否
馬克·魯法洛—《任務》
否
魯弗斯·休伊爾—《外交家》
否
諾亞·懷爾——《深淵》
是
This market will resolve according to the person who wins the 2026 Emmy award for “Outstanding lead actor in a drama series”.
If for any reason no winner is declared by October 31, 2026, 11:59 PM ET, or in case of overall cancellation or a tie for winner, this market will resolve in favor of the nominee which comes first in alphabetical order.
The primary resolution source for this market will be official information from the Academy of Television Arts & Sciences and the Emmys, including data from their websites (e.g. https://theemmys.tv/, https://www.televisionacademy.com/) and the live broadcast of the award ceremony, however a consensus of credible reporting may also be used.
市場開放時間: Jul 9, 2026, 9:08 PM ET
已提議結果: 否
無爭議
最終結果: 否
This market will resolve according to the person who wins the 2026 Emmy award for “Outstanding lead actor in a drama series”.
If for any reason no winner is declared by October 31, 2026, 11:59 PM ET, or in case of overall cancellation or a tie for winner, this market will resolve in favor of the nominee which comes first in alphabetical order.
The primary resolution source for this market will be official information from the Academy of Television Arts & Sciences and the Emmys, including data from their websites (e.g. https://theemmys.tv/, https://www.televisionacademy.com/) and the live broadcast of the award ceremony, however a consensus of credible reporting may also be used.
已提議結果: 否
無爭議
最終結果: 否
Noah Wyle’s repeat frontrunner status for Outstanding Lead Actor in a Drama Series stems from his layered performance as Dr. Michael “Robby” Robinavitch in The Pitt’s second season, which earned the HBO Max medical drama a leading 25 Emmy nominations. Building on his 2025 win for the freshman run, Wyle benefited from the show’s real-time format, strong reviews, and his additional producing and directing nods, creating clear awards momentum ahead of the September 14 ceremony. Traders priced in overwhelming consensus around the returning champion, consistent with historical patterns favoring repeat winners in the category when supported by guild and critics’ recognition. An upset would have required a late surge from nominees like Gary Oldman or Sterling K. Brown overcoming The Pitt’s dominance, an outcome that appeared improbable given the show’s broad industry backing.
基於Polymarket數據的AI實驗性摘要。這不是交易建議,也不影響該市場的結算方式。 · 更新於



警惕外部連結哦。
警惕外部連結哦。
Frequently Asked Questions